top of page

Speakers

Dr. David Bartley

Panelist

Chairman for the Department of Chemistry and Biochemistry at Adrian College

David is a medicinal chemist by training and is an Associate Professor of Biochemistry and serves as Department Chair at Adrian College. He also serves as the director of the Honors Program. The main focus of his job is educating undergraduate students.  In this role, David teaches all of the biochemistry courses at Adrian as well as lectures and labs in a number of chemistry courses.  While teaching is his primary job responsibility, he performs undergraduate research with a small number of student each semester.  His research projects are often designed with the input of the students and are chosen with the primary objective of teaching students new techniques and instilling excellent recordkeeping rather than generating publications.

Dr. Sarah Mikelman

Panelist

Medical Writer at OxfordPharmaGenesis

Sarah is a medical writer at a medical communications agency outside of Philadelphia. She primarily works in educational and promotional products. Sarah received her Bachelor of Science in Cell and Molecular Biology from Tulane University in 2009. Sarah graduated from the University of Michigan with a PhD in Pharmacology under Prof. Gnegy in 2016. She has won several awards, including an award for the best poster at the 41st Pharmacology Colloquium at Michigan State University.

 

Dr. Bruce Roth

Keynote Speaker

Retired Senior Vice President of Small Molecule Drug Discovery and Co-Leader of Genentech Research

Bruce held the role of Senior Vice President of Small Molecule Drug Discovery at Genentech for 7 years before retiring from his position at the end of 2017.  Before working at Genentech, Bruce held positions at Warner-Lambert/ Parke-Davis Co and Pfizer, and served as an adjunct associate professor in the Department of Medicinal Chemistry at the University of Michigan from 1996-2007.Throughout his career, he has been credited as the inventor or co-inventor on 43 issued U.S. patents and has won numerous awards.  As a member of Warner-Lambert/ Parke-Davis Co in Ann Arbor, MI, Bruce synthesized the compound that would ultimately be marketed as Lipitor®.

 

Dr. Anthony Emanuele

Panelist

Senior Development Scientist at Beckman Coulter Inc.

Anthony's current role is based in Southfield, MI focusing on new product development for molecular and immuno-based diagnostics. Previously, he was a member of Beckman Coulter's Science and Engineering Innovation Program, where high-potential individuals are selected to rotate through multiple areas of the company.  During the program he completed two rotations in R&D and one in Marketing/Product Management. Anthony graduated from the University of Michigan with a PhD in Medicinal Chemistry in 2015. During his time at the University of Michigan, he received the prestigious American Foundation for Pharmaceutical Education (AFPE) Fellowship.

 

Dr. Carole Parent

Panelist

Lynn and Raymond W. Ruddon Collegiate Professor of Cancer Biology and Pharmacology at the University of Michigan

Carole's scientific interests are centered on studying how cells detect and respond to external chemotactic signals and, in particular, how the spatial and temporal relay of chemotactic signals between cells impact single and group cell migration. Her work has implications in a variety of processes, including inflammation, tissue repair and cancer metastasis. She runs a laboratory consisting of undergraduate and graduate students as well as postdoctoral fellows and senior scientists. Carole acts as their primary mentor by guiding them in their studies and experiments.  She also teaches Pharmacology classes to large groups of either undergraduate or graduate students. 

1
2
3
4
5
bottom of page